可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]逯建华,汤迎春.心房颤动的诊断与治疗进展[J].中国现代医药杂志,2011,13(3):134-135.
[2]翁银燕.肥胖与房颤关系的临床研究[D].哈尔滨:哈尔滨医科大学,2009.
[3]马 君,李学文.房颤发生与维持的研究进展[J].中西医结合心脑血管病杂志,2011,9(4):474-477.
[4]马利芹,耿光瑞,孙秀梅.大黄减肥复方对家兔脂肪代谢的影响[J].黑龙江畜牧兽医,2009(3):107-108.
[5]王国贤,王蕾蕾.葛根素对糖尿病大鼠心肌纤维化的影响[J].江苏大学学报(医学版),2011,21(4):294-297.
[6]陈 凡,颜宇波,杨天伦,等.氯沙坦和曲尼司特抗高血压大鼠心肌纤维化的对比观察[J].中国现代医学杂志,2010,20(7):1000-1007.
[7]聂园园,仇小强.心肌细胞凋亡与心血管疾病关系的研究进展[J].实用医学杂志,2012,28(2):324-326.
[8]Chiou CW,Eble JN,Zipes DP.Efferent vagal innervation of the canine atria and sinus and atrioventricular nodes.The third fat pad[J].Circulation,1997,95(11):2573-2584.
[9]Teresa SM.肥胖系阵发性房颤进展为永久性房颤的危险因素之一[J].国外医学·老年医学分册,2009,30(5):237-238.
[10]Wang TJ,Parise H,Levy D,et al.Obesity and the risk of new-onset atrial fibrillation[J].JAMA,2004,292(20):2471-2477.
[11]Malavazos AE,Cereda E,Morricone L,et al. Monocyte chemoattractant protein 1 (MCP-1) and visceral fat[J].J Clin Endocrinol Metab,2005,90(5):3128.
[12]Kremen J,Dolinkova M,Krajickova J,et al.Increased subcutaneous andepicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistanc[J].J Clin Endocrinol Metab,2006,91(11):4620-4627.
[13]王洪涛,郑强荪,杨玉辉,等.犬心脏第3脂肪垫对左心房及左上肺静脉电生理特性的影响[J].心脏杂志,2006,18(4):386-387.
[14]杨玉辉,郑强荪,董建军,等.消融犬右肺静脉脂肪垫对心房及右上肺静脉电生理特性及房颤诱发的影响[J].心脏杂志,2006,18(1):28-30.
[15]Werner N,Nickenig G,Laufs U. Pleiotropic effects of HMG-CoA reductase inhibitors[J].Basic Res Cardiol,2002,97(3):105-116.
[16]Zhang J,Cheng X,Liao YH,et al.Simvastatin regulates myocardial cytokine expression and improves ventricular remodeling in rats after acute myocardial infarction[J].Cardiovasc Drugs Ther, 2005,19(1):13-21.
[17]Wallace CK,Stetson SJ,Kucuker SA,et al.Simvastatin decreases myocardial tumor necrosis factor alpha content in heart transplant recipients[J].J Heart Lung Transplant,2005,24(1):46-51.
[18]尚福军,王捷频,郑强荪,等.辛伐他汀抑制大鼠心肌细胞TNF-α的表达及其与活性氧的关系[J].中国临床药理学与治疗学,2009,14(12):1379-1385.